Display options
Share it on

Alzheimers Dement (Amst). 2017 Mar 31;8:18-25. doi: 10.1016/j.dadm.2017.03.003. eCollection 2017.

Changes in metabolic risk factors over 10 years and their associations with late-life cognitive performance: The Multi-Ethnic Study of Atherosclerosis.

Alzheimer's & dementia (Amsterdam, Netherlands)

Timothy M Hughes, Suzanne Craft, Laura D Baker, Mark A Espeland, Stephen R Rapp, Kaycee M Sink, Alain G Bertoni, Gregory L Burke, Rebecca F Gottesman, Erin D Michos, José A Luchsinger, Annette L Fitzpatrick, Kathleen M Hayden

Affiliations

  1. Department of Internal Medicine, Section on Gerontology and Geriatric Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
  2. Department of Biostatistics, Wake Forest School of Medicine, Winston-Salem, NC, USA.
  3. Department of Psychiatry and Behavioral Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
  4. Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, NC, USA.
  5. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  6. The Ciccarone Preventive Cardiology Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  7. Department of Medicine, Columbia University Medical Center, New York, NY, USA.
  8. Department of Epidemiology, Columbia University Medical Center, New York, NY, USA.
  9. Department of Family Medicine, University of Washington, Seattle, WA, USA.
  10. Department of Epidemiology, University of Washington, Seattle, WA, USA.
  11. Department of Global Health, University of Washington, Seattle, WA, USA.
  12. Department of Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, USA.

PMID: 28435852 PMCID: PMC5390661 DOI: 10.1016/j.dadm.2017.03.003

Abstract

BACKGROUND: We examined whether changes in metabolic factors over 10 years were associated with cognitive performance.

METHODS: Participants from the Multi-Ethnic Study of Atherosclerosis were followed since baseline (2000-2002) with five clinical examinations. At exam 5 (2010-2012), they received a short cognitive battery (Cognitive Abilities Screening Instrument [CASI], Digit Symbol Coding [DSC], and Digit Span [DS]). We examined associations between baseline metabolic factors and their changes over time before cognitive testing.

RESULTS: Among 4392 participants, baseline metabolic disorders (fasting glucose, systolic and diastolic blood pressures) were significantly associated with poorer CASI, DSC, and DS scores measured 10 years later. Increases in blood pressure were associated with lower cognitive performance. Results did not differ by race/ethnicity and were stronger among those without the

CONCLUSIONS: Cognitive performance was associated with antecedent abnormalities in glucose metabolism and blood pressure increases. Findings appeared stronger among

Keywords: Brain; Cognitive function; Metabolic disorders; Metabolism

References

  1. Clin Chem. 1972 Jun;18(6):499-502 - PubMed
  2. Aging Ment Health. 2009 Mar;13(2):171-82 - PubMed
  3. J Alzheimers Dis. 2013;33 Suppl 1:S263-75 - PubMed
  4. J Appl Physiol (1985). 2008 Nov;105(5):1652-60 - PubMed
  5. Am J Geriatr Psychiatry. 2015 Jul;23(7):684-97 - PubMed
  6. J Am Geriatr Soc. 2015 Jun;63(6):1075-83 - PubMed
  7. J Alzheimers Dis. 2013;35(4):789-97 - PubMed
  8. J Clin Endocrinol Metab. 2015 Jul;100(7):2682-9 - PubMed
  9. Am J Epidemiol. 2002 Nov 1;156(9):871-81 - PubMed
  10. Arch Neurol. 2009 Mar;66(3):300-5 - PubMed
  11. JAMA Neurol. 2014 Oct;71(10):1218-27 - PubMed
  12. Neurology. 2013 Dec 3;81(23):2024-7 - PubMed
  13. Neurology. 2015 Jun 9;84(23):2329-37 - PubMed
  14. Circulation. 2009 Oct 20;120(16):1640-5 - PubMed
  15. Ann Intern Med. 2014 Dec 2;161(11):785-93 - PubMed
  16. Neurobiol Dis. 2014 Dec;72 Pt A:3-12 - PubMed
  17. Neurodegener Dis Manag. 2015;5(2):121-35 - PubMed
  18. Diabetologia. 2015 Nov;58(11):2545-53 - PubMed
  19. Stroke. 2011 Sep;42(9):2672-713 - PubMed
  20. Dement Geriatr Cogn Disord. 2014;38(5-6):337-46 - PubMed
  21. J Alzheimers Dis. 2015;44(2):355-73 - PubMed
  22. Neurobiol Aging. 2006 Mar;27(3):451-8 - PubMed
  23. Biochim Biophys Acta. 2016 May;1862(5):983-91 - PubMed
  24. JAMA Neurol. 2013 Aug;70(8):972-80 - PubMed
  25. Eur Neuropsychopharmacol. 2014 Aug;24(8):1303-8 - PubMed
  26. Psychosom Med. 2015 Jul-Aug;77(6):653-63 - PubMed
  27. Alzheimers Dement. 2014 Sep;10(5):562-70 - PubMed
  28. Lancet Neurol. 2011 Nov;10(11):969-77 - PubMed
  29. Alzheimers Res Ther. 2015 Jul 12;7(1):48 - PubMed
  30. Eur J Pharmacol. 2008 May 6;585(1):97-108 - PubMed

Publication Types

Grant support